Advertisement

Topics

“The discovery of this mechanism, linked to epigenetic phenomena, may one day pave the way for management of MS using small molecules that inhibit chromatin modification enzymes,” says Christian Muchardt of @institutpasteur: http://ow.ly/o3uw50u9JIa

21:55 EDT 13 May 2019 | Genetic Engineering News

“The discovery of this mechanism, linked to epigenetic phenomena, may one day pave the way for management of MS using small molecules that inhibit chromatin modification enzymes,” says Christian Muchardt of : http://ow.ly/o3uw50u9JIa 

Original Article: “The discovery of this mechanism, linked to epigenetic phenomena, may one day pave the way for management of MS using small molecules that inhibit chromatin modification enzymes,” says Christian Muchardt of @institutpasteur: http://ow.ly/o3uw50u9JIa

NEXT ARTICLE

More From BioPortfolio on "“The discovery of this mechanism, linked to epigenetic phenomena, may one day pave the way for management of MS using small molecules that inhibit chromatin modification enzymes,” says Christian Muchardt of @institutpasteur: http://ow.ly/o3uw50u9JIa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Epigenetics
The development and maintenance of an organism is orchestrated by a set of chemical reactions that switch parts of the genome off and on at strategic times and locations. Epigenetics is the study of these reactions and the factors that influence them. ...

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...